PodMed – Week of January 30, 2017


Culture of Clostridium difficile, an anaerobic bacterium. This bacterium is in some cases able to cause severe diarrhoea leading to pseudomembranous colitis and death. Clostridium difficile has caused many nosocomial outbreaks in hospitals. Viable spores of the bacterium can survive months or years on surfaces. This culture is NAP1 or CD027, an epidemic subtype of toxigenic Clostridium difficile.

This week’s topics include at home sleep studies, an antibody for C.difficile infection, using big data to examine medical devices, and language concordance and type 2 diabetes control.

Program notes:

0:35 Treatment of C. difficile
1:35 Antitoxin antibody
2:32 Phase III trial
2:55 Post market surveillance data of devices
3:55 Vascular closure devices
4:50 Registry is voluntary
5:22 Language concordant providers
6:23 Compared with those who stayed had better control
7:27 Can sleep studies be done at home?
8:28 Can we use to guide CPAP?
9:28 Still requires education
10:11 End

Related blog: https://podblog.blogs.hopkinsmedicine.org/2017/01/27/treating-c-dif/